Director/PDMR Shareholding
15 December 2017 12:00 GMT TRANSACTION BY PERSON DISCHARGING MANAGERIAL RESPONSIBILITIES Disclosure under Article 19 of the EU Market Abuse Regulation AstraZeneca PLC (the Company) announces that, on 14 December 2017, it was notified by Pascal Soriot, a Director of the Company, that, on 13 December 2017, Mr Soriot ceased to be beneficially interested in 40,148 Ordinary Shares of $0.25 each in the Company, following the gift of those shares to family members for nil consideration. The attached notification, made in accordance with the requirements of the EU Market